GlassScriptPhysician profile
Mohammed M Rahman
NPI 1215971262
$6,974.05
in general payments reported to CMS, 2019-2025
43 companies · $1,277 in 2025
The $1,277 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547 · 2020: $379 · 2021: $1,374 · 2022: $1,276 · 2023: $885 · 2024: $1,236 · 2025: $1,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,397.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $999.81 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $830.66 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Merck Sharp & Dohme LLC | $758.06 | 2019-2025 | Verquvo, Gardasil 9, Capvaxive |
| Gilead Sciences, INC. | $685.64 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $441.27 | 2021-2024 | Xifaxan, Trulance |
| Amgen INC. | $348.66 | 2020-2025 | Otezla, Repatha, Otezla |
| Astellas Pharma US INC | $322.63 | 2021-2025 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $304.91 | 2021-2025 | Shingrix, Arexvy, Bexsero |
| Exact Sciences Corporation | $231.48 | 2024-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $218.78 | 2022-2024 | Mounjaro, Jardiance, Emgality |
| Ardelyx, INC. | $206.21 | 2024-2025 | Ibsrela |
| Novo Nordisk INC | $187.84 | 2020-2022 | |
| Amarin Pharma, INC. | $147.93 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $137.20 | 2024-2025 | Voquezna |
| Shield Therapeutics INC | $116.60 | 2023-2024 | Accrufer |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.